GSK

  • Anoro 2019 report

    Anoro 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Benlysta 2019 report

    Benlysta 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 17 Pages The 5 Key Questions Addressed by this Report:...

  • Bexsero 2019 report

    Bexsero 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Boostrix 2019 report

    Boostrix 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Breo 2019 report

    Breo 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Fluarix 2019 report

    Fluarix 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Flulaval 2019 report

    Flulaval 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Menveo 2019 report

    Menveo 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Nucala 2019 report

    Nucala 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Pediarix 2019 report

    Pediarix 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Shingrix 2019 report

    Shingrix 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Trelegy Ellipta 2019 report

    Trelegy Ellipta 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 24 Pages The 5 Key Questions Addressed by this...